middle.news
Firebrick Pharma Unlocks Indonesia Market with Nasodine Approval
9:06am on Friday 27th of March, 2026 AEDT
•
Healthcare
Read Story
Firebrick Pharma Unlocks Indonesia Market with Nasodine Approval
9:06am on Friday 27th of March, 2026 AEDT
Key Points
Nasodine Nasal Spray approved for import and distribution in Indonesia
Indonesia’s population of 285 million offers substantial market potential
Agreement executed with PT Pyridam Farma Tbk for regulatory and import services
Firebrick to focus on local packaging and securing marketing partnerships
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Firebrick Pharma (ASX:FRE)
OPEN ARTICLE